FindTrial
Sign In

Treating teeth sensitivity with iontophoresis as a standalone treatment and along with commercially available toothpastes (Biomin and Perfora)

Comparative evaluation of efficacy of iontophoresis in the treatment of dentinal hypersensitivity (DH) with iontophoresis as a standalone treatment and in combination with commercially available toothpastes (Biomin and perfora) in the management of Dentinal hypersensitivity at baseline and 3 months: Randomized clinical study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/095193
Enrollment
27
Registered
2025-09-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K038- Other specified diseases of hard tissues of teeth

Interventions

Intervention1: Iontophoresis (as a standalone treatment) and Iontophoresis in combination with commercially available toothpastes (Biomin and Perfora).: The intervention will be carried out using iont

Sponsors

Dr Vimarsha R Achar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients must have at least two sensitive permanent tooth surfaces on the buccal/facial aspects of incisors, canines, or premolars. 2.Patients should be systemically healthy. 3.Patients with wasting diseases and/or gingival recession will be included. 4.must provide signed informed consent. 5.Sensitive tooth surfaces should present with wasting diseases and/or gingival recession.

Exclusion criteria

Exclusion criteria: 1.Patients who have undergone active periodontal treatment within the last 6 months. 2.Pregnant or lactating females. 3.Patients with deleterious habits such as smoking and/or alcohol consumption. 4.Patients already undergoing treatment for dentinal hypersensitivity (DH). 5.Patients with a known allergy. 6.Patients with pacemakers. 7.Patients with sensitivity due to gastroesophageal reflux disease (GERD). 8.Patients with medical (including psychiatric and pharmacotherapeutic) histories that could compromise the study. 9.Patients with systemic conditions that are etiologic or predisposing to dentinal hypersensitivity, including eating disorders. 10.Patients who have received any dental treatment that might interfere with the action of the desensitizing agent being tested. 11.Patients presenting with any other oral pathology. 12.Individuals with orthodontic appliances or bridgework that could interfere with evaluation. 13.Dentinal hypersensitivity will be assessed by air blast stimulation; patients unable to undergo this assessment will be excluded.

Design outcomes

Primary

MeasureTime frame
Verbal rating scale Visual analogue scale plaque indexTimepoint: baseline 2 weeks 1 month 3 months—

Secondary

MeasureTime frame
air blast test tactile testTimepoint: baseline 2 weeks 1 month 3 months—

Countries

India

Contacts

Public ContactDr Sangeetha U Nayak

Manipal College of Dental Sciences, Mangalore

sangeeta.nayak@manipal.edu07022020172

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026